ArticleVirus genes2026
Emergence of foot-and-mouth disease virus SAT 1 topotype III in Iran: molecular and phylogenetic analysis.
Article in Virus genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foot-and-mouth disease (FMD) is one of the most devastating viral diseases affecting cloven-hoofed livestock, leading to significant economic losses. Among the seven established serotypes of this disease, three (O, A, and Asia 1) have been continuously reported and are routinely included in the vaccination schedule in Iran. In response to a severe, atypical FMD outbreak that emerged in October 2025, we collected clinical samples from affected cattle and sheep. We conducted RT-PCR, sequenced the products, and subsequently performed phylogenetic analysis of the viral sequences against all available global topotypes to determine the origin of the incursion. We identified the causative agent as a SAT 1 serotype, a strain not included in the Iranian vaccination schedule. Phylogenetic analysis revealed that the Iranian strains cluster within topotype III, indicating the closest evolutionary relationship to Botswana isolates. This study provides the first definitive evidence of the emergence and transmission of FMDV SAT 1/III in Iran, posing a severe threat to regional livestock industries, which mandates an urgent reassessment of current FMD surveillance and vaccine strategies and highlights a significant new risk across the Middle East region. The unexpected emergence of this lineage necessitates further investigation into the source of the incursion, with potential pathways including laboratory-derived origins or the use of contaminated or incompletely inactivated vaccines.
Indexed as
Identifiers
42014576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.